Zankiren

占吉仑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameZankiren
Drug Alias NameA-72517Abbott-72 517
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionRenin inhibitors
TargetsRenin
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A